Table 4.
The Effects of the Covariates in the Zero-Inflated Model Predicting Number of Hospitalizations at 16 Weeks and Number of Days in the Hospital
Outcome: Number of Hospitalizations at 16 Weeks | ||||
Covariate | Estimated Coefficient |
Standard Error | t | P-value |
Number of hospitalization before baseline |
0.38 | 0.16 | 2.40 | 0.0165 |
Overall severity reduced (≥50%) | −0.87 | 0.31 | −2.79 | 0.0053 |
Overall severity reduced (0–49%) | −0.66 | 0.38 | −1.75 | 0.0802 |
Baseline symptom severity | 0.02 | 0.01 | 2.10 | 0.0357 |
Trail Arm (ATSM vs. NASM) | −0.25 | 0.30 | −0.82 | 0.4112 |
Outcome: Number of Nights in the Hospital | ||||
Covariate | Estimated Coefficient |
Standard Error | t | P-value |
Number of Nights Stayed in Hospital Before Wave 1 |
0.03 | 0.01 | 2.46 | 0.0139 |
Overall severity reduced (≥50%) | −0.53 | 0.11 | −4.74 | <0.0001 |
Overall severity reduced (0–49%) | −0.60 | 0.13 | −4.67 | <0.0001 |
Baseline symptom severity | 0.01 | 0.002 | 5.12 | <0.0001 |
Trail Arm (ATSM vs. NASM) | 0.02 | 0.09 | 0.25 | 0.8024 |